Pure Global

Roche Diagnostics GmbH - Manufacturer Profile

Explore comprehensive manufacturer profile for Roche Diagnostics GmbH through Pure Global AI's free Australia TGA ARTG medical device database. This company has manufactured 207 medical devices registered with TGA ARTG across 4 device classes. This manufacturer is based in Germany. Their registration history spans from Aug 17, 2010 to Feb 22, 2024.

This page provides detailed insights including recent device registrations, risk class distribution (Class IIb: 61, Class III: 81, Class IIa: 52, Class I: 13), and complete regulatory information from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices.

Free Manufacturer Profile
Powered by Pure Global AI
207 Devices
4 Device Classes
Roche Diagnostics GmbH
Manufacturer โ€ข Germany
207
Total Devices
4
Device Classes
2010
Earliest
2024
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Device Registrations
Latest 10 TGA ARTG device registrations

Elecsys HCV Duo (cobas e 402/801) - Hepatitis C virus antibody/antigen IVD, kit, chemiluminescent immunoassay

ARTG 442030

Class III
Feb 22, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

Elecsys HCV Duo (cobas e 402/801) - Hepatitis C virus antibody/antigen IVD, kit, chemiluminescent immunoassay

Class III
Feb 22, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

Hepatitis E virus IVDs

Class IIb
Feb 15, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

Hepatitis E virus IVDs

ARTG 441110

Class IIb
Feb 15, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

PreciControl HBeAg quant - Hepatitis B virus e-antigen IVD, control

Class III
Feb 13, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

PreciControl HBeAg quant - Hepatitis B virus e-antigen IVD, control

ARTG 440890

Class III
Feb 13, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

Elecsys HBeAg quant (cobas e 411/601/602) - Hepatitis B virus e-antigen IVD, kit, chemiluminescent immunoassay

Class III
Feb 13, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

Elecsys HBeAg quant (cobas e 402/801) - Hepatitis B virus e-antigen IVD, kit, chemiluminescent immunoassay

Class III
Feb 13, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

Elecsys HBeAg quant (cobas e 411/601/602) - Hepatitis B virus e-antigen IVD, kit, chemiluminescent immunoassay

ARTG 440910

Class III
Feb 13, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

Elecsys HBeAg quant (cobas e 402/801) - Hepatitis B virus e-antigen IVD, kit, chemiluminescent immunoassay

ARTG 440850

Class III
Feb 13, 2024

Sponsor: Roche Diagnostics Australia Pty Limited

Risk Class Distribution
Devices by risk class
Class I
13
6.3% of total
Class IIa
52
25.1% of total
Class IIb
61
29.5% of total
Class III
81
39.1% of total